Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2010
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101468993B Isoquinolinium compound or its salts, pharmaceutical composition containing the same, preparation and use thereof
10/13/2010CN101200470B Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof
10/12/2010US7812177 Potassium channel opener having benzofuroindole skeleton
10/12/2010US7812170 Insecticides
10/12/2010US7812043 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7812021 {(3RS,4SR)-3-(3,4-dichloro-phenyl)-4-[(RS)-1-(4-trifluoromethyl-phenoxy)-ethyl]-pyrrolidin-1-yl}-(4-methanesulfonyl-piperazin-1-yl)-methanone, for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder
10/12/2010CA2477903C Substituted benzofurans useful as protein kinase b activators
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/07/2010WO2010114958A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010112520A1 Spiro derivatives for the modulation of stearoyl-coa desaturase
10/07/2010WO2010112413A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
10/07/2010US20100254910 Methods and compositions for diagnostic and therapeutic targeting of cox-2
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2754646A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/06/2010EP1515965B1 Phenylaminopyrimidines and their use as rho-kinase inhibitors
10/06/2010CN101855224A Equilibrative nucleoside transporter ENT1 inhibitors
10/06/2010CN101855218A Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
10/06/2010CN101851505A Coumarin organic electroluminescent fluorescent materials and synthesis method thereof
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/06/2010CN101851243A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/06/2010CN101851242A Preparation method of asenapine intermediate
10/06/2010CN101851195A Quinoline compound and synthetic method and application thereof in synthesizing camptothecin alkaloid
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807688 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders
10/05/2010US7807687 Reaction of a 2,4-disubstituted quinolinone with an aldehyde in the presence of a base to prepare a benzylidene hydroquinolinone, reaction of product with benzamidinium hydrochloride under basic conditions to prepare a 1,4,5,6-tetrahydropyrido[3,2-h]quinazoline, oxidation; performance efficiency; OLED
10/05/2010US7807670 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
09/2010
09/30/2010WO2010110400A1 Heterocyclic compound
09/30/2010WO2010110380A1 Fused piperidine compound and pharmaceutical agent comprising same
09/30/2010WO2010110026A1 Pharmaceutical composition for metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver
09/30/2010WO2010109329A1 Furopyrimidinedione derivatives as trpa1 modulators
09/30/2010WO2010109050A1 Cromenopyrazole derivatives as cannabinoid receptor ligands
09/30/2010WO2010109005A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010WO2010108995A1 Dinitroxide biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249417 Novel naphthyridine derivative monohydrate and method for producing the same
09/30/2010US20100249415 Process for preparation of temsirolimus
09/30/2010US20100249386 Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (dnp)
09/30/2010US20100249276 Curatives for epoxy compositions
09/30/2010US20100249174 Ccr1 antagonists and methods of use therefor
09/30/2010US20100249172 9-chloro noscapine and its use in treating cancers, including drug-resistant cancers
09/30/2010US20100249099 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010US20100249094 Compounds for the Treatment of Hepatitis C
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010CA2756535A1 Furopyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2753868A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/29/2010EP2233487A1 Spirocyclic cyclohexane derivatives
09/29/2010EP2233479A1 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
09/29/2010EP2231677A2 Trisubstituted piperidines as renin inhibitors
09/29/2010EP2231676A1 (e)-n-{3-[1-(8-fluoro-11h-10-oxa-1-aza-dibenzo[a,d]-cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
09/29/2010EP2231638A1 Phthalazinone derivatives
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231558A1 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
09/29/2010EP1727817B1 Azabicyclooctan-3-one derivatives and use thereof
09/29/2010EP1638957B1 N-heterocyclyl phenyl-substituted cyclic ketoenols
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1421074B1 Novel compounds
09/29/2010CN1972938B 环状胺化合物 Cyclic amine compound
09/29/2010CN101848905A Process for the enantioselective preparation of pregabalin
09/29/2010CN101845018A Non-catechol aporphine compound as well as pharmaceutic composition and application thereof
09/29/2010CN101302220B N-benzoyl rhodamine B hydrazine, preparation and use thereof
09/28/2010US7803952 Manufacture of lactones
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803943 Use of bridged nucleic acid fluorescent dyes, such as phenanthridinium dyes, cyanine dyes, or acridinium dyes each having an ammonium group and anion; bridging group can be -CH2-CONH-(CH2-CH2-O)x-(CH2)2-NHCO-CH2- ; low background fluorescence in the absence of nucleic acids; noncarcinogenic, stability
09/28/2010US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
09/28/2010US7803803 Tetrahydrofuro[3,2-B] pyrrol-3-ones as cathepsin K inhibitors
09/23/2010WO2010106457A2 3-oxa-7-azabicyclo[3.3.1]nonanes
09/23/2010WO2009132774A8 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
09/23/2010US20100240897 Spirocyclic Cyclohexane Compounds
09/23/2010US20100240688 1,3-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1 h-1,4 bipyridinyl-2-ones
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010CA2754523A1 3-oxa-7-azabicyclo[3.3.1]nonanes
09/22/2010EP2229375A1 Gamma secretase modulators
09/22/2010EP2044078B1 Camptothecin derivatives with antitumor activity
09/22/2010EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/22/2010EP1796669B1 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/22/2010CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
09/22/2010CN101842376A Tetracyclic indole derivatives and their use for treating or preventing viral infections
09/22/2010CN101838273A Method for extracting strychnine from semen strychni
09/22/2010CN101838272A Method for preparing annotine
09/22/2010CN101837075A Composition for preventing and treating dementia
09/21/2010US7799931 Spirocyclic cyclohexane compounds
09/21/2010US7799922 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799798 Spiroheterocyclic compounds and their uses as therapeutic agents
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799791 osteoporosis, Paget's disease, Chagas's disease, malaria, gingival diseases, hypercalemia, bone disorders, bone cancer, metastasis pain; e.g. N-(1-cyclopentyl-2-(6-methoxy-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)-2-oxoethyl)-4-(2-(4-methylpiperazin-1-yl)thiazol-4-yl)benzamide
09/21/2010US7799785 such as (4aS,13bR,14aR)-6-fluoro-1,4a,9,13b,14,14a-hexahydrodibenzo[3',4':6',7']-cyclohepta[1',2':4,5]pyrrolo[1,2-c]imidazole-3(2H)-thione, having binding affinities towards serotonin receptors, dopamine receptors and with norepinephrine reuptake inhibition properties; antidepressants; neuroleptic agents
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 298